Enzyre B.V.

Enzyre B.V. is a biotechnology company based in the Netherlands, founded in 2016 as a spin-out from Radboud University Medical Center. The company specializes in near-patient diagnostics for blood coagulation management, aiming to enhance personalized medicine and improve patient outcomes, particularly for hemophilia. Enzyre is headquartered in Nijmegen and operates with a small team, focusing on innovative solutions that bring laboratory capabilities directly to patients.

The core product of Enzyre is the ENZYSYSTEM, a point-of-care diagnostic platform that allows for real-time blood coagulation analysis. This system includes a painless blood sampling device, single-use microfluidic cartridges called ENZYCARD, and a reusable processor known as ENZYPAD. These components work together to provide immediate results and data transfer to healthcare professionals, facilitating remote monitoring and personalized care. Enzyre has established partnerships, including a strategic collaboration with Takeda Pharmaceutical Company, to further develop its diagnostic solutions for hemophilia patients.